TardiMed Sciences LLC

Insider Reports History

Reporting-owner location: Tarrytown, NY
Latest reporting-owner signature: /s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for TardiMed Sciences LLC

Form 4 holding 10%+ Owner

Timber Pharmaceuticals, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 3,508,567
Estimated value: $5,715,456
Report date: 02 Sep 2021
Price: $1.63
Ownership: Direct

Form 4 holding 10%+ Owner

PaxMedica, Inc.

Security class: Common Stock
Shares / value: 7,336,745
Estimated value: $1,355,830
Report date: 30 Aug 2022
Price: $0.1848
Ownership: Direct

Insider Reports Filed by TardiMed Sciences LLC

4

PaxMedica, Inc.

Report period: 30 Aug 2022
Transactions: 1
Transaction value: +$498,750
Accepted by SEC: 01 Sep 2022, 16:07
Role: 10%+ Owner
Next action: Open filing details

3

PaxMedica, Inc.

Report period: 12 Aug 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 12 Aug 2022, 18:31
Role: 10%+ Owner
Next action: Open filing details

4

Timber Pharmaceuticals, Inc.

Report period: 02 Sep 2021
Transactions: 1
Transaction value: -$210,960
Accepted by SEC: 02 Sep 2021, 19:11
Role: 10%+ Owner
Next action: Open filing details

4

Timber Pharmaceuticals, Inc.

Report period: 30 Aug 2021
Transactions: 3
Transaction value: -$368,266
Accepted by SEC: 01 Sep 2021, 17:29
Role: 10%+ Owner
Next action: Open filing details

4

Timber Pharmaceuticals, Inc.

Report period: 24 Aug 2021
Transactions: 3
Transaction value: -$275,630
Accepted by SEC: 26 Aug 2021, 18:47
Role: 10%+ Owner
Next action: Open filing details

4

Timber Pharmaceuticals, Inc.

Report period: 18 Aug 2021
Transactions: 3
Transaction value: -$168,170
Accepted by SEC: 20 Aug 2021, 18:19
Role: 10%+ Owner
Next action: Open filing details

4

Timber Pharmaceuticals, Inc.

Report period: 14 Jun 2021
Transactions: 2
Transaction value: -$221,480
Accepted by SEC: 15 Jun 2021, 18:49
Role: 10%+ Owner
Next action: Open filing details

4

Timber Pharmaceuticals, Inc.

Report period: 08 Jun 2021
Transactions: 3
Transaction value: -$750,216
Accepted by SEC: 10 Jun 2021, 18:06
Role: 10%+ Owner
Next action: Open filing details

4

Timber Pharmaceuticals, Inc.

Report period: 28 May 2021
Transactions: 3
Transaction value: -$84,019
Accepted by SEC: 02 Jun 2021, 17:57
Role: 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .